Neuphoria Therapeutics (NEUP) Stock Price, Quote, News & History

Comments

Neuphoria Therapeutics Inc (NEUP) Stock Price, Quote, News & History

NEUPNASDAQ

Trade with Public

$4.32

-0.22-4.85%

At close: Mar 6, 4:00 PM EST

$4.45

0.133.01%

After Hours: Mar 6, 9:12 AM EST

OverviewNews Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$4.48

Close

$4.32

Volume / Avg.

71.36K / 54.17K

Day Range

$4.32 - $4.64

52 Wk Range

3.65 - 21.40

Market Cap

$23.93M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

59

Short Interest

0.62%

Days to Cover

1.63

Recent Neuphoria Therapeutics Inc News

Nasdaq Surges 1%; Procter & Gamble Posts Upbeat Earnings

Avi Kapoor

US Stocks Mixed; Coca-Cola Posts Upbeat Earnings

Avi Kapoor

PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

715.64K

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

5.01M

Free Cash Flow (TTM)

715.64K

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

5.72M

Analyst Trends and Forecast

1

Sep 25

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$8.73M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.80

PB Ratio (TTM)

0.83

Earnings Yield % (TTM)

-15.03%

Earnings Yield % (FWD)

-53.03%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$5.51

Company Debt

Total Debt

$33.01K

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$13.65M

Debt to Equity

0.01

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$4.48

Close

$4.32

Volume / Avg.

71.36K / 54.17K

Day Range

$4.32 - $4.64

52 Wk Range

3.65 - 21.40

Market Cap

$23.93M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

59

Short Interest

0.62%

Days to Cover

1.63

About

Sector

Health Care

Industry

Biotechnology

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Neuphoria Therapeutics (NEUP) stock?

A

You can purchase shares of Neuphoria Therapeutics (NASDAQ:NEUP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Neuphoria Therapeutics (NEUP) competitors?

A

Other companies in Neuphoria Therapeutics’s space includes: Kyntra Bio Inc (NASDAQ:KYNB), Skye Bioscience Inc (NASDAQ:SKYE), Intensity Therapeutics Inc (NASDAQ:INTS), Evaxion AS (NASDAQ:EVAX) and Nanoviricides Inc (AMEX:NNVC).

Q

What is the forecast, or price target, for Neuphoria Therapeutics (NEUP) stock?

A

Neuphoria Therapeutics has a consensus price target of $21.00.

Q

What is the current price for Neuphoria Therapeutics (NEUP)?

A

The stock price for Neuphoria Therapeutics (NASDAQ: NEUP) is $4.45 last updated March 6, 2026 at 9:12 AM EST.

Q

Does Neuphoria Therapeutics (NEUP) pay a dividend?

A

There are no upcoming dividends for Neuphoria Therapeutics.

Q

When is Neuphoria Therapeutics (NASDAQ:NEUP) reporting earnings?

A

Neuphoria Therapeutics does not have any upcoming earnings scheduled.

Q

Is Neuphoria Therapeutics (NEUP) going to split?

A

There is no upcoming split for Neuphoria Therapeutics.

Q

What sector and industry does Neuphoria Therapeutics (NEUP) operate in?

A

Neuphoria Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Intensity Therapeutics Inc

NNVC

Barinthus Biotherapeutics PLC

NASDAQ:BRNS

$0.60

2.05%

Vistagen Therapeutics Inc

Key Statistics

Open

$4.48

Close

$4.32

Volume / Avg.

71.36K / 54.17K

Day Range

$4.32 - $4.64

52 Wk Range

3.65 - 21.40

Market Cap

$23.93M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

59

Short Interest

0.62%

Days to Cover

1.63

Recent Neuphoria Therapeutics Inc News

Nasdaq Surges 1%; Procter & Gamble Posts Upbeat Earnings

Avi Kapoor

US Stocks Mixed; Coca-Cola Posts Upbeat Earnings

Avi Kapoor

PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

715.64K

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

5.01M

Free Cash Flow (TTM)

715.64K

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

5.72M

Analyst Trends and Forecast

1

Sep 25

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$8.73M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.80

PB Ratio (TTM)

0.83

Earnings Yield % (TTM)

-15.03%

Earnings Yield % (FWD)

-53.03%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$5.51

Company Debt

Total Debt

$33.01K

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$13.65M

Debt to Equity

0.01

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$4.48

Close

$4.32

Volume / Avg.

71.36K / 54.17K

Day Range

$4.32 - $4.64

52 Wk Range

3.65 - 21.40

Market Cap

$23.93M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

59

Short Interest

0.62%

Days to Cover

1.63

About

Sector

Health Care

Industry

Biotechnology

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry